A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
Clinical trial NCT03901469 · TERMINATED
Trial details
- NCT number
- NCT03901469
- Sponsor
- Zenith Epigenetics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-26
- Primary completion
- 2024-03-07
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.